全球 DNA聚合酵素市場規模、佔有率、成長分析（按類型、按應用） - 產業預測，2024-2031 年

Global DNA Polymerase Market Size, Share, Growth Analysis, By Type(Taq Polymerase, Pfu Polymerase), By Application(Polymerase Chain Reaction, DNA Sequencing) - Industry Forecast 2024-2031

出版日期: 2024年03月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球DNA聚合酵素市場規模為1.326億美元，預測期間（2024-2031年）複合年成長率為1.30%，從2023年的1.3432億美元增加至2031年的1.4895億美元。

全球 DNA聚合酵素市場取得了顯著成長，預計未來幾年將進一步擴大。 DNA聚合酵素在生物技術、實驗室、醫學診斷和法醫學等多個領域中發揮著至關重要的作用。推動市場成長軌跡的主要因素包括慢性病盛行率的增加、基因研究的進步以及對個人化醫療的需求不斷增加。成長的主要驅動力之一是遺傳性疾病和癌症、糖尿病和心血管疾病等慢性病的盛行率不斷上升。隨著這些疾病在全球範圍內不斷增加，DNA 複製、擴增和序列測定等任務對 DNA聚合酵素的需求也在增加。另一個主要的成長要素是快速成長的個人化醫療領域。 DNA聚合酵素有助於識別與特定疾病相關的遺傳變異、突變和生物標記。這有助於針對個別患者標靶治療和客製化治療方法，從而改善臨床結果。然而，全球DNA聚合酵素市場也面臨挑戰。一是DNA聚合酵素的高成本，尤其是高保真、專門的酵素。這些酵素的高成本限制了它們的可用性，特別是在預算緊張的小型實驗室和醫療機構中。此外，市場競爭激烈，許多公司提供各種 DNA聚合酵素產品。這加劇了市場參與企業之間的競爭，導致價格壓力，並使小公司難以獲得重要的市場佔有率。此外，嚴格的監管要求給市場參與者帶來了障礙，特別是在醫療診斷和治療應用方面。遵守監管標準並獲得必要的核准既耗時又昂貴，使情況更加複雜。儘管有這些挑戰，全球 DNA聚合酵素市場仍有望保持成長軌跡。技術進步、研發投資的增加以及 DNA聚合酵素應用的擴大預計將在短期內推動市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Thermo Fisher Scientific Inc.-United States
Merck KGaA-Germany
New England Biolabs-United States
Promega Corporation-United States
Agilent Technologies Inc.-United States
Illumina, Inc.-United States
QIAGEN NV-Netherlands
Takara Bio Inc.-Japan
Bio-Rad Laboratories, Inc.-United States
F. Hoffmann-La Roche Ltd.-Switzerland
Sigma-Aldrich Corporation（now part of Merck KGaA）-United States
LGC Limited-United Kingdom
Enzo Biochem, Inc.-United States
Lucigen Corporation-United States
Bioline GmbH（a Meridian Bioscience Company）-Germany
Toyobo Co., Ltd.-Japan
Genesee Scientific Corporation-United States
Vazyme Biotech Co., Ltd.-China
Takara Bio USA Holdings, Inc.-United States
Jena Bioscience GmbH-Germany

簡介目錄

Product Code: SQMIG35H2206

Global DNA Polymerase Market size was valued at USD 132.6 million in 2022 and is poised to grow from USD 134.32 million in 2023 to USD 148.95 million by 2031, at a CAGR of 1.30% during the forecast period (2024-2031).

The global DNA polymerase market is experiencing notable growth and is anticipated to further expand in the forthcoming years. DNA polymerases play a pivotal role across various domains, encompassing biotechnology, research laboratories, medical diagnostics, and forensics. The market's upward trajectory is chiefly propelled by several factors, including the escalating prevalence of chronic diseases, advancements in genetic research, and the growing demand for personalized medicine. One of the primary drivers of growth is the increasing incidence of genetic disorders and chronic ailments such as cancer, diabetes, and cardiovascular diseases. As these conditions continue to rise globally, the demand for DNA polymerases for tasks like DNA replication, amplification, and sequencing also escalates. Another significant growth catalyst is the burgeoning field of personalized medicine. DNA polymerases are instrumental in identifying genetic variations, mutations, and biomarkers linked to specific diseases. This facilitates targeted therapies and customized treatment regimens for individual patients, resulting in enhanced clinical outcomes. Nevertheless, the global DNA polymerase market encounters certain challenges. One such obstacle is the high cost associated with DNA polymerases, particularly high-fidelity and specialized enzymes. The expense of these enzymes may restrict their accessibility, especially for smaller research laboratories and medical facilities operating with limited budgets. Moreover, the market is highly competitive, with numerous players offering a diverse array of DNA polymerase products. This intensifies competition among market participants, leading to pricing pressures and making it difficult for smaller entities to gain significant market share. Additionally, stringent regulatory requirements, particularly in medical diagnostics and therapeutic applications, pose hurdles for market players. Compliance with regulatory standards and securing necessary approvals can be time-consuming and costly, further complicating the landscape. Despite these challenges, the global DNA polymerase market is poised to sustain its growth trajectory. Technological advancements, heightened investments in research and development activities, and the expanding applications of DNA polymerases are anticipated to propel market growth in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the global DNA polymerase market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global DNA Polymerase Market Segmental Analysis

Global DNA polymerase market is segmented based on type, application, and region. By type, the market is segmented into taq polymerase, pfu polymerase, and proprietary enzyme blends. By application, the market is segmented into polymerase chain reaction, DNA sequencing, DNA cloning, SNP analysis, next generation sequencing. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global DNA Polymerase Market

The surge in chronic diseases such as cancer and cardiovascular ailments has spurred an increased demand for diagnostic and treatment technologies. Consequently, in the post-COVID era, there has been a notable rise in the requirement for DNA polymerase, which plays a pivotal role in the amplification process of PCR (Polymerase Chain Reaction). Specifically, the treatment of cancer has witnessed heightened utilization of high-fidelity DNA polymerases. This has underscored the necessity for an advanced DNA polymerase capable of accurately replicating DNA and detecting mutations with a high degree of sensitivity and specificity. As a result, there has been a development of new DNA polymerase products with enhanced fidelity, speed, and overall performance. Moreover, specialized polymerases adept at amplifying and identifying DNA sequences associated with various diseases have also been introduced to the market.

Restraints in the Global DNA Polymerase Market

The rising cost of DNA polymerases presents a significant hurdle to the growth of the DNA polymerase market, hindering the adoption of innovative technologies that depend on costly enzymes. The developments in biotechnology have significantly impacted the pricing of DNA polymerases, leading to a steep increase in their costs. Consequently, some research laboratories or medical facilities may encounter challenges in affording these expensive polymerases.

Market Trends of the Global DNA Polymerase Market

With the increasing prominence of precision medicine, DNA polymerases are being employed to pinpoint specific genetic variations and mutations linked to diseases. This facilitates the creation of personalized treatments and therapies tailored to individual patients, thereby enhancing clinical outcomes.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global DNA Polymerase Market by Type

Market Overview
Taq Polymerase
Pfu Polymerase
and Proprietary Enzyme Blends

Global DNA Polymerase Market by Application

Market Overview
Polymerase Chain Reaction
DNA Sequencing
DNA Cloning
SNP Analysis
and Next Generation Sequencing

Global DNA Polymerase Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN N.V. - Netherlands
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigma-Aldrich Corporation (now part of Merck KGaA) - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited - United Kingdom
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lucigen Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioline GmbH (a Meridian Bioscience Company) - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toyobo Co., Ltd. - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genesee Scientific Corporation - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vazyme Biotech Co., Ltd. - China
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio USA Holdings, Inc. - United States
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jena Bioscience GmbH - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments